We are live on ! Find out more
RP

Regeneron Pharmaceuticals Portfolio holdings

AUM $47.9M
1-Year Est. Return 29.29%
This Fund
S&P 500
This Quarter Est. Return
+20.99%
1 Year Est. Return
+29.29%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$1.49B
AUM Growth
+$251M
Cap. Flow
-$6.3M
Cap. Flow %
-0.42%
Top 10 Hldgs %
100%
Holding
6
New
–
Increased
–
Reduced
–
Closed
2

Top Buys

No buys this quarter

Top Sells

1
TSVT
2seventy bio
TSVT
+$6.2M
2
BLUE
bluebird bio
BLUE
+$102K

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ALNY icon
1
Alnylam Pharmaceuticals
ALNY
$38.5B
$1.45B 97.6%
4,444,445
– –
NTLA icon
2
Intellia Therapeutics
NTLA
$1.82B
$34.7M 2.34%
3,702,995
– –
ACET icon
3
Adicet Bio
ACET
$79.9M
$591K 0.04%
60,511
– –
ADVM
4
DELISTED
Adverum Biotechnologies
ADVM
$389K 0.03%
180,909
– –
BLUE
5
DELISTED
bluebird bio
BLUE
– –
-21,000
Closed -$102K
TSVT
6
DELISTED
2seventy bio
TSVT
– –
-1,254,827
Closed -$6.2M

Similar funds

PFA
Portland Financial Advisors Port Washington, New York $48.1M AUM 10.13% 1-Year Est. Return
CCG
Capital CS Group Irvine, California $48.4M AUM 11.64% 1-Year Est. Return
IPHI
Inflection Point Holdings II New York $47.3M AUM
FWM
FLP Wealth Management Bentonville, Arkansas $48.5M AUM 23.48% 1-Year Est. Return
EGI
EAM Global Investors Solana Beach, California $47.1M AUM 320.45% 1-Year Est. Return
CT
ClearAlpha Technologies Greenwich, Connecticut $48.6M AUM 13.34% 1-Year Est. Return
PEP
Pickering Energy Partners Houston, Texas $47.1M AUM 78.22% 1-Year Est. Return
FCM
Firsthand Capital Management San Jose, California $46.9M AUM 114.33% 1-Year Est. Return